ОбзорГрафикНовостиTraderScreen

Morgan Stanley Knock-Out BDT/  DE000MD3VS95  /

EUWAX
13.05.2024  18:22:34 Изменение- Бид22:00:34 Предложение22:00:34 Базовый актив Цена исполнения Дата истечения Тип опциона
1.30EUR - -
Величина цены спроса: -		 -
Величина цены предложения: -		 BERTRANDT AG O.N. 27.0069 - 31.12.2078 Call
TeleTrader 8:35 Bitcoin falls under $68K on ETFs outflows
Newsfile Corp 8:34 PNK Group Invests in New Production Facilities
TeleTrader 8:24 Singapore Airlines to compensate injured in turbulence
GlobeNewswire 8:20 Himax to Make Strategic Investment in FOCI Private Placement Financing; Companies to Unite FOCI’s Wo...
GlobeNewswire 8:15 ROHM’s New TRCDRIVE pack™ with 2-in-1 SiC Molded Module: Significantly Reduces the Size of Electric ...
TeleTrader 8:04 Europe eyes higher open with US CPI, Fed's decision in focus
GlobeNewswire 8:00 FTI Consulting Appoints Senior Forensic Expert Dr. Stefan Heissner to the Forensic and Litigation Co...
TeleTrader 8:00 UK unemployment rate at 4.4% in April
GlobeNewswire 8:00 Bedford Metals Engages CanExplor Management for Satellite Survey of Ubiquity Lake Uranium Project
GlobeNewswire 8:00 ArcelorMittal Announces Pricing of Bond Issue
GlobeNewswire 8:00 Progress on share buyback programme
GlobeNewswire 8:00 Viridien Joins Forces with Ranch Computing to Supercharge the Digital Media Landscape
GlobeNewswire 7:49 Ibanera Launches FedNow for Real-Time Payments Across the US
GlobeNewswire 7:45 GRITSTONE BIO, INC. (NASDAQ: GRTS) INVESTOR ALERT: Bernstein Liebhard LLP Announces that a Securitie...
TeleTrader 7:35 Russian bomber jet crashes in North Ossetia
TeleTrader 7:25 Asia mostly lower with China CPI in sight
GlobeNewswire 7:00 Nykode Therapeutics Announces mRNA-LNP Cancer Vaccine Demonstrates Superior Efficacy
GlobeNewswire 7:00 Feutune Light Acquisition Corporation Announces that It Will Adjourn the Special Meeting of Stockhol...
GlobeNewswire 7:00 Molecular Partners and Orano Med Share Positive Preclinical Data of their DLL3-Targeting Radio-DARPi...
GlobeNewswire 7:00 NMD Pharma Initiates Phase 2b Trial of NMD670 in Generalized Myasthenia Gravis Patients
TeleTrader 6:57 Japan's Suzuki pushes for Russia sanctions talks at G7
TeleTrader 6:52 N. Korea's vice public security minister heads off to Russia
TeleTrader 6:28 Gallant criticizes Gantz's resignation from Israeli govt
TeleTrader 6:21 Speaker Johnson, NRCC chair allegedly to meet with Trump
GlobeNewswire 6:00 Adcytherix Launches with € 30m in Seed Funding to Develop Next Generation Antibody Drug Conjugates